Treatment with anti-LIF increased CXCL9 and decreased CCL2 expression (Fig. 4b), while inducing immune cell infiltration into the Matrigel surrounding the tumor specimen (Fig. 4b). The gene discussed is CCL2; the disease is neoplasm.